Health & bio

Genetic Hearing Loss Gene Therapy Otarmeni Receives Accelerated Approval on April 23

Lunsotogene parvec-cwha (Otarmeni) received accelerated approval on April 23, marking the first gene therapy for inherited hearing loss.

Primary sources · 1
FDA
← View the full 2026-04-23 (Wed) issue
What you're reading now arrives in your inbox daily at 21:00 UTC.

Get today's brief every day at 21:00 UTC

7 must-reads · 17 fields · tracked storylines delivered to your inbox daily. Pick only the fields you want; unsubscribe anytime.

Past issues →